Ostergaard, DK
Brian Ostergaard, Graested DK
Patent application number | Description | Published |
---|---|---|
20120172811 | AUTO-PRIMING INJECTION DEVICE - The invention relates to an injection device ( | 07-05-2012 |
20120184917 | FROST PROTECTED INJECTION DEVICE - The invention relates to an injection device ( | 07-19-2012 |
Christian Ostergaard, Vaerlose DK
Patent application number | Description | Published |
---|---|---|
20080235583 | Method and System for File Fast-Forwarding and Rewind - A method of scrolling or fast-forwarding/rewind includes enabling a fast forwarding/rewind mode of a device to review a file, activating an input device to change a fast forwarding/rewind speed at a first rate, and activating the input device at least one subsequent time to change the fast forwarding/rewind speed at a second rate that is different from the first. | 09-25-2008 |
20080301590 | NAVIGATION OF A DIRECTORY STRUCTURE - A user interface for navigating a directory structure includes a first screen area for showing a directory path to a currently identified target location and a second screen area for showing the contents of a currently identified target location, a user control having a plurality of predetermined modes of actuation, there being at least one predetermined mode for navigating within an area, and at least one predetermined mode for navigating between the areas. The user interface allows the user to navigate the directory structure, and operate on the contents, using a conveniently small number of inputs. | 12-04-2008 |
20080313554 | Apparatus, method, computer program and user interface for storing information - An apparatus including: a memory for storing files in a storage system including a plurality of folders; a display for presenting the plurality of folders and the files stored in the plurality of folders to a user of the apparatus; a user input device for enabling a user to designate a folder as a destination folder and for enabling a user to select a file to be transferred from a first folder to the designated destination folder; a processor configured to determine, in response to user selection of a file in a first folder, if a destination folder has been designated by a user and, if a destination folder has been designated by a user, to transfer the selected file from the first folder to the designated destination folder, and if a destination folder has not been designated by a user to enable a user to designate a destination folder and to transfer the selected file to the designated destination folder. | 12-18-2008 |
20080320415 | APPARATUS, METHOD AND COMPUTER-READABLE STORAGE MEDIUM FOR ACCESSING MEDIA CONTENT - An apparatus is configured to present a graphical user interface (GUI) that includes category, subcategory and media content fields. The category field identifies therein categories associated with pieces of media content. The apparatus is configured to receive selection of an identified category, and in response thereto, (a) note the selected category in the category field of the GUI; and (b) identify, in the subcategory field of the GUI, subcategories associated with piece of media content, and in the hierarchy, logically underneath the selected category. The apparatus is also configured to receive selection of an identified subcategory, and in response thereto, (a) note the selected subcategory in the subcategory field of the GUI; and (b) identify, in the media content field of the GUI, pieces of media content logically underneath the selected subcategory in the hierarchy. The apparatus is then configured to receive selection of an identified piece of media content. | 12-25-2008 |
20100131846 | METHODS, RENDERING APPLICATION, PORTABLE APPARATUS, AND COMPUTER PROGRAM FOR CREATING A PLAYLIST - A mobile communication apparatus includes a display and means for navigating among items displayed on the display, arranged to enable selection of a first item, in the display view, from a multitude of lists of items. Upon selection of the first item, the selected first item is associated with a playlist including at least the selected item, wherein the item or items in the playlist are arranged in sequential order. A corresponding application, apparatus, user interface, and computer program is also disclosed. | 05-27-2010 |
Elsebet Ostergaard, Kobenhavn DK
Patent application number | Description | Published |
---|---|---|
20110053985 | NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS - This invention relates to novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives useful as monoamine neurotransmitter re-uptake inhibitors. | 03-03-2011 |
Hans P. Ostergaard, Viborg DK
Patent application number | Description | Published |
---|---|---|
20160049713 | Stress Relieved High Power RF Circuit - The present invention is directed to an RF device that includes a laminate structure having a ceramic layer having a predetermined thermal conductivity that is a function of a predetermined RF device operating temperature. The ceramic layer forms a first major surface of the laminate structure and a second major ceramic surface is bonded to a layer of thermoplastic material that is, in turn, bonded to a conductive layer. The thermoplastic material has a coefficient of thermal expansion that substantially matches the conductive layer. A first circuit arrangement is disposed on the first major surface of the laminate structure and it includes a first RF circuit structure having a predetermined geometry and predetermined electrical characteristics. The laminate structure is configured to dissipate thermal energy generated by the at least one first RF circuit structure via substantially the entire second major surface of the laminate structure. | 02-18-2016 |
Hans P. Ostergaard, Skaldehojvej DK
Patent application number | Description | Published |
---|---|---|
20120229230 | Impedance Transforming Coupler - A coupler circuit that includes two parallel coupled transmission lines (first transmission line and second transmission line) and a third transmission line, one end of the third transmission line connects to the end of first transmission line at one side, the other end of the third transmission line connects to the end of the second transmission line at the other side. Various coupling value and impedance transforming ratio can be achieved by select corresponding even and odd mode impedance of the coupled transmission lines and characteristic impedance of the crossing transmission line. | 09-13-2012 |
Henrik Ostergaard, Olstykke DK
Patent application number | Description | Published |
---|---|---|
20080227691 | Blood Coagulation FVIII Analogues - The invention is related to a FVIII analogue which has a circulation time in the blood stream before activation of at least about two times of that of native FVIII and a week after injection to a patient retains at least about 5% of the FVIII activity compared to the initial activity peak value reached after injection. The claimed FVIII analogues comprise a targeted disruption of one or more of the clearance sites in the FVIII molecule by introduction of at least one N-glycosylation site or by introduction of at least one Cys residue within or spatially close to the clearance site in the A2 domain or a combination thereof. The inserted cysteine residues may be further modified by conjugation with a chemical group increasing the molecular weight of the FVIII analogue. | 09-18-2008 |
20090041744 | Dimeric and Multimeric FVIIa Compounds - The present invention relates to dimeric or multimeric FVIIa compounds comprising at least two FVIIa polypeptides covalently connected such as to retain the intrinsic catalytic activity of the FVIIa polypeptides. | 02-12-2009 |
20090055942 | Human Coagulation Factor VII Polypeptides - The present invention relates to novel human coagulation Factor Vila variants having substitutions of one or more amino acids at a position selected from the group consisting of position 172, 173, 175, 176, 177, 196, 197, 198, 199, 200, 203, 235, 237, 238, 239, 240, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 297, 299, 319, 320, 321, 327, 341, 363, 364, 365, 366, 367, 370, 373 corresponding to amino acid positions of SEQ ID NO:1 and wherein said Factor VII polypeptide exhibits increased resistance to inactivation by an endogenous inhibitor of said FVII polypeptide relative to wild-type human FVIIa. | 02-26-2009 |
20090252720 | Prolonged FIX Analogues and Derivatives - The invention is related to FIX analogues which have an increased circulation time in the blood stream before activation compared to that that of native FIX (and a week after injection to a patient retains at least about 5% of the FIX activity compared to the initial activity peak value reached after injection). The claimed FIX analogues comprise an inserted cysteine residue which has been further modified by conjugation with a chemical group increasing the molecular weight of the FIX analogue. | 10-08-2009 |
Henrik Ostergaard, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20080200651 | Selective Reduction and Derivatization of Engineered Proteins Comprising at Least One Non-Native Cysteine - The present invention relates to method for selective reduction and derivatization of recombinantly prepared engineered proteins comprising at least one non-native cysteine, wherein the reduction reaction is conducted in the presence of a redox buffer or in the presence of a triarylphosphine reducing agent. | 08-21-2008 |
Jesper Ostergaard, Farum DK
Patent application number | Description | Published |
---|---|---|
20130059313 | ANALYTE QUANTIFICATION USING FLOW INDUCED DISPERSION ANALYSIS - A method for quantitative characterization of non-covalent interactions and analyte quantification in nanoliter samples is described. The procedure is based on Flow Induced Dispersion Analysis (FIDA), of which the only system requirements is a narrow tube, capillary or channel equipped with a detector. The technique can be implemented using standard equipment such as High Performance Liquid Chromatography (HPLC), Flow Injection Analysis (FIA) or Capillary Electrophoresis (CE). | 03-07-2013 |
Jette Buch Ostergaard, Kobenhavn N DK
Patent application number | Description | Published |
---|---|---|
20140005217 | Nalmefene for reduction of alcohol consumption in specific target populations | 01-02-2014 |
Lars Ostergaard, Aarhus DK
Patent application number | Description | Published |
---|---|---|
20140099337 | Pneumococcal Vaccine and Uses Thereof - The present invention relates to new pneumococcal vaccines. The invention also relates to vaccination of subjects, in particular immunocompromised subjects, against pneumoccocal infections using said novel pneumococcal vaccines. | 04-10-2014 |
Lars Ostergaard, Randers Nv DK
Patent application number | Description | Published |
---|---|---|
20110123375 | ROTATIONAL DIRECTION INDICATOR - The inventive rotational direction indicator for an electric motor having a cooling fan has a baffle element which can be moved between two positions and which can be arranged on an electric motor with a cooling fan in such a way that the baffle element is positioned in an airstream of the cooling fan whose direction depends on the rotational direction of the electric motor, and said baffle element is respectively moved into one of its two positions by said electric motor as a function of the direction of the airstream. The rotational direction indicator has a display unit which is designed to visually indicate the position of the baffle element and can be arranged on an outer side of the electric motor. In addition, the rotational direction indicator has a display actuating unit which connects the display unit and baffle element to one another, and transmits the position of the baffle element to the display unit. | 05-26-2011 |
Lars Ostergaard, Lystrup DK
Patent application number | Description | Published |
---|---|---|
20090324553 | Chimeric Viral Envelopes - The invention relates to chimeric polytropic viral envelope polypeptides and uses thereof, as well as to polynucleotides encoding said chimeric polypeptides and constructs comprising said polypeptides and/or polynucleotides. The invention also relates to chimeric retroviral envelope polypeptides, polynucleotides and vectors encoding said chimeric retroviral envelope polypeptides, virus particles and cells harbouring said chimeric envelope polypeptides. Said chimeric polypeptide comprise an envelope polypeptide, or fragment thereof, and a polypeptide sequence of a receptor binding region, ligand or polypeptide sequence of a ligand binding region, and optionally a linker sequence. The invention include methods of targeting receptors, methods of treatment and methods for delivery of agents using said chimeric retroviral envelope polypeptides. The invention is applicable for directed targeting and controlled fusion of virus particles with other cellular membranes. | 12-31-2009 |
Lars Henrik Ostergaard, Charlottenlund DK
Patent application number | Description | Published |
---|---|---|
20150152452 | Enzymatic Oxidation of 5-Hydroxymethylfurfural and Derivatives Thereof - Provided herein are enzymatic methods for oxidation of 5-hydroxymethylfurfural (HMF) and HMF derivatives. | 06-04-2015 |
Lars Jørgen Ostergaard, Lystrup DK
Patent application number | Description | Published |
---|---|---|
20130108653 | BIVALENT MOLECULES FOR HIV ENTRY INHIBITION | 05-02-2013 |
Ole Ostergaard, Herning DK
Patent application number | Description | Published |
---|---|---|
20120076444 | PIZZA PACKAGING - A packaging ( | 03-29-2012 |
Peter Rahbek Ostergaard, Virum DK
Patent application number | Description | Published |
---|---|---|
20090047387 | Protease variants - The invention relates to a novel 3D structure encoding a | 02-19-2009 |
20090092707 | POLYPEPTIDES OF ALICYCLOBACILLUS SP. - Isolated polypeptides are disclosed selected from the group consisting of: | 04-09-2009 |
20090148924 | PROTEASES AND VARIANTS THEREOF - The present invention relates to isolated proteases of the RP-II type and variants of RP-II proteases exhibiting improved properties in comparison to the parent RP-II protease, DNA constructs and vectors coding for the expression of said proteases and variants, host cells capable of expressing the proteases and variants from the DNA constructs, as well as a method of producing them by cultivating said host cells. The proteases may advantageously be used as constituents in detergent compositions and additives, optionally in combination with other enzymes such as proteases, lipases, cellulases, amylases, peroxidases or oxidases. | 06-11-2009 |
20110135619 | Polypeptides of Alicyclobacillus sp. - Isolated polypeptides are disclosed selected from the group consisting of: | 06-09-2011 |
20120321746 | Proteases - Proteases derived from | 12-20-2012 |
20130189732 | Protease Variants - The invention relates to a novel 3D structure encoding a | 07-25-2013 |
20140147553 | Process for Preparing A Baked Product with Anti-Staling Amylase and Peptidase - The present invention provides processes for preparing dough which comprises at least one anti-staling amylase and at least one peptidase. In addition, the present invention provides baked products produced there from which have a desirable degree of softness and improved springiness. | 05-29-2014 |
20140255550 | Protease Variants - The invention relates to a novel 3D structure encoding a | 09-11-2014 |
Rasmus C. Ostergaard, Copenhagen O DK
Patent application number | Description | Published |
---|---|---|
20120266997 | FLEXIBLE PIPE AND A METHOD OF PRODUCING A FLEXIBLE PIPE - The invention relates to a flexible pipe comprising an axis and a tubular innermost sealing sheath surrounding said axis, said innermost sealing sheath being surrounded by at least one outer armoring layer. The innermost sealing sheath has an inner side which is the side of the innermost sealing sheath comprising said axis. On the inner side of said innermost sealing sheath the flexible pipe comprises at least one carcass comprising a plurality of annular armoring members. | 10-25-2012 |
Soeren Ostergaard, Broenshoej DK
Patent application number | Description | Published |
---|---|---|
20130040877 | LONG-ACTING Y2 RECEPTOR AGONISTS - The present invention relates to PYY analogues or derivatives thereof comprising at least one alteration selected from the group consisting of substitutions, insertions, deletions and modifications and optionally a serum albumin binding side chain comprising an alkyl chain with at least 14 carbon atoms. Moreover, the invention relates to compositions hereof and methods of treatment of conditions responsive to Y2 receptor modulation. | 02-14-2013 |
Soren Ostergaard, Broenshoej DK
Patent application number | Description | Published |
---|---|---|
20090192072 | Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, certain of the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonists may also be developed as therapeutics. | 07-30-2009 |
Soren Ostergaard, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20110039779 | IGF-1R BINDING PROTEINS AND ANTAGONISTS - The present invention is drawn to new peptides and proteins that bind to human insulin-like growth factor-1 receptor (HIGF-IR), as well as nucleic acids encoding the same, vectors and cells comprising such nucleic acids, pharmaceutical compositions comprising such compounds, and methods of using any thereof, are provided. | 02-17-2011 |
Soren Ostergaard, Copenhagen O DK
Patent application number | Description | Published |
---|---|---|
20110124556 | Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, certain of the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonists may also be developed as therapeutics. | 05-26-2011 |